DK1817342T3 - Fremgangsmåde til affinitetsrensning - Google Patents

Fremgangsmåde til affinitetsrensning

Info

Publication number: DK1817342T3
Authority: DK; Denmark
Prior art keywords: affinity purification; affinity; purification
Prior art date: 2004-12-02

Application number

DK05817207.3T

Other languages

English (en)

Inventor

Wilhelmus Josephus Johanna Hermans

Haaft Mark Ronald Ten

Anja Overweel

Original Assignee

Bac Ip B V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-02

Filing date

2005-12-02

Publication date

2013-06-03

2005-12-02 Application filed by Bac Ip B V filed Critical Bac Ip B V

2013-06-03 Application granted granted Critical

2013-06-03 Publication of DK1817342T3 publication Critical patent/DK1817342T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Analytical Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Peptides Or Proteins (AREA)

DK05817207.3T 2004-12-02 2005-12-02 Fremgangsmåde til affinitetsrensning DK1817342T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04078282		2004-12-02
PCT/NL2005/000829 WO2006059904A1 (en)	2004-12-02	2005-12-02	Method for affinity purification

Publications (1)

Publication Number	Publication Date
DK1817342T3 true DK1817342T3 (da)	2013-06-03

Family

ID=34928702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05817207.3T DK1817342T3 (da)	2004-12-02	2005-12-02	Fremgangsmåde til affinitetsrensning

Country Status (9)

Country	Link
US (4)	US20080249285A1 (da)
EP (1)	EP1817342B1 (da)
JP (2)	JP5875745B2 (da)
CN (1)	CN101072794B (da)
CA (1)	CA2589839C (da)
DK (1)	DK1817342T3 (da)
ES (1)	ES2408256T3 (da)
PT (1)	PT1817342E (da)
WO (1)	WO2006059904A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010533004A (ja) *	2007-07-13	2010-10-21	バクアイピーベスローテンフェンノートシャップ	哺乳動物ＩｇＧと結合する単一ドメイン抗原結合タンパク質
BRPI0820156B8 (pt) *	2007-11-12	2021-05-25	Chreto Aps	processo para purificação de uma biomolécula alvo
WO2012105833A1 (en)	2011-02-01	2012-08-09	Bac Ip B.V.	Antigen-binding protein directed against epitope in the ch1 domain of human igg antibodies
JPWO2013125221A1 (ja) *	2012-02-21	2015-07-30	静岡県	抗体精製用アフィニティリガンド
CN103113455B (zh) *	2012-11-23	2015-07-22	南宁市蓝光生物技术有限公司	血凝素肽标签重组蛋白免疫亲和纯化富集柱制备及其应用
US10294306B2 (en) *	2015-05-28	2019-05-21	Bio-Rad Laboratories, Inc.	Affinity ligands and methods relating thereto
US11136609B2 (en) *	2015-11-09	2021-10-05	National University Corporation Kyoto Institute Of Technology	Separating agent for human serum-derived IgG polyclonal antibodies, and method for separating human serum-derived IgG polyclonal antibodies using same
JP6549061B2 (ja)	2016-05-09	2019-07-24	富士フイルム株式会社	撮影装置および方法並びに撮影装置制御プログラム
DE102018110252A1 (de)	2018-04-27	2019-10-31	Infineon Technologies Ag	Transceiver, System mit Transceivern und Signal
CN111423509B (zh) *	2019-01-10	2021-07-09	瑞阳(苏州)生物科技有限公司	抗hsa单域抗体及其融合蛋白的亲和层析纯化方法
CN109628436B (zh) *	2019-01-18	2022-03-29	重庆派金生物科技有限公司	一种固定重组人精氨酸酶的制备方法
WO2026011056A1 (en)	2024-07-02	2026-01-08	Cerberus Therapeutics	Compositions and methods for improving immune response

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0345466A3 (en) *	1988-05-10	1991-04-17	EASTMAN KODAK COMPANY (a New Jersey corporation)	Generation of chimeric antibodies in vivo by site-specific recombination
US6476198B1 (en) *	1993-07-13	2002-11-05	The Scripps Research Institute	Multispecific and multivalent antigen-binding polypeptide molecules
RU2192281C2 (ru) *	1996-10-11	2002-11-10	Бристол-Маерс Сквибб Компани	Способы и композиции для иммуномодуляции
BR9813276A (pt) *	1997-10-27	2000-08-22	Unilever Nv	Proteìna multivalente de ligação de antìgeno, sequências de nucleotìdeos, vetor de expressão, célula hospedeira, processo para preparação de proteìna multivalente de ligação de antìgeno, e, uso da mesma
WO1999037681A2 (en) *	1998-01-26	1999-07-29	Unilever Plc	Method for producing antibody fragments
ATE535154T1 (de) *	1998-03-12	2011-12-15	Vhsquared Ltd	Produkten die inaktivierte hefen oder schimmel enthalten, die auf ihrer aussenoberfläche aktive antikörper haben
DE60042789D1 (de) *	1999-11-29	2009-10-01	Bac Ip B V	Immobilisierte antigenbindende moleküle aus einer domäne
CA2505316C (en)	2002-11-08	2014-08-05	Ablynx N.V.	Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
WO2004041867A2 (en) *	2002-11-08	2004-05-21	Ablynx N.V.	Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
JP2010533004A (ja) *	2007-07-13	2010-10-21	バクアイピーベスローテンフェンノートシャップ	哺乳動物ＩｇＧと結合する単一ドメイン抗原結合タンパク質

2005
- 2005-12-02 WO PCT/NL2005/000829 patent/WO2006059904A1/en not_active Ceased
- 2005-12-02 JP JP2007544292A patent/JP5875745B2/ja not_active Expired - Lifetime
- 2005-12-02 PT PT58172073T patent/PT1817342E/pt unknown
- 2005-12-02 CN CN2005800415117A patent/CN101072794B/zh not_active Expired - Lifetime
- 2005-12-02 DK DK05817207.3T patent/DK1817342T3/da active
- 2005-12-02 ES ES05817207T patent/ES2408256T3/es not_active Expired - Lifetime
- 2005-12-02 US US11/792,145 patent/US20080249285A1/en not_active Abandoned
- 2005-12-02 EP EP05817207A patent/EP1817342B1/en not_active Expired - Lifetime
- 2005-12-02 CA CA2589839A patent/CA2589839C/en not_active Expired - Lifetime
2013
- 2013-12-06 JP JP2013253665A patent/JP6009431B2/ja not_active Expired - Lifetime
2015
- 2015-08-06 US US14/820,446 patent/US20160024148A1/en not_active Abandoned
2017
- 2017-06-07 US US15/616,781 patent/US20170369527A1/en not_active Abandoned
2021
- 2021-04-23 US US17/239,195 patent/US20210347816A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2589839C (en)	2016-04-05
JP2008521890A (ja)	2008-06-26
JP5875745B2 (ja)	2016-03-02
US20080249285A1 (en)	2008-10-09
JP2014077001A (ja)	2014-05-01
US20160024148A1 (en)	2016-01-28
JP6009431B2 (ja)	2016-10-19
US20210347816A1 (en)	2021-11-11
WO2006059904A1 (en)	2006-06-08
PT1817342E (pt)	2013-05-15
US20170369527A1 (en)	2017-12-28
CA2589839A1 (en)	2006-06-08
CN101072794B (zh)	2012-07-04
ES2408256T3 (es)	2013-06-19
EP1817342B1 (en)	2013-03-06
EP1817342A1 (en)	2007-08-15
CN101072794A (zh)	2007-11-14

Publication	Publication Date	Title
IL187642A0 (en)	2008-03-20	METHODS FOR PURIFYING PROTEINS HAVING Fc REGIONS
DE112006001685A5 (de)	2008-04-03	Trennverfahren
DK1869065T3 (da)	2020-06-08	Fremgangsmåde til kromatografi med svag opdeling
DK1879623T3 (da)	2012-12-17	Genterapi til rygmarvssygdomme
DE602005021424D1 (de)	2010-07-08	Schweißverfahren
FI20055581A0 (fi)	2005-10-28	Erotusmenetelmä
DE502005010728D1 (de)	2011-02-03	Rerunabhängiger lenkmomentüberlagerung
DE602005014583D1 (de)	2009-07-09	Fahrradsteuerapparat
FI20040098L (fi)	2005-07-24	Kaasukromatografi
DE602005006185D1 (de)	2008-06-05	Entwicklungsverfahren
DK1989189T3 (da)	2013-10-21	Adsorbenter til proteinoprensning
ATE442898T1 (de)	2009-10-15	Filtrationsverfahren
ITMI20042238A1 (it)	2005-02-19	Composti per fluoropolirterei
DK1817342T3 (da)	2013-06-03	Fremgangsmåde til affinitetsrensning
FI20041702A0 (fi)	2004-12-31	Toimipuskurointi menettelyn valvontaan
BRPI0615165A2 (pt)	2016-09-13	método de tratamento de infertilidade
DE602006012689D1 (de)	2010-04-15	Überprüfungsverfahren
DE502004011729D1 (de)	2010-11-18	Parkassistent zum Parallel-Einparken
DE502005003987D1 (de)	2008-06-19	Prozesssteuersystem
DE602005010809D1 (de)	2008-12-18	Lenkapparat
GB0503942D0 (en)	2005-04-06	Purification process
DE602005003884D1 (de)	2008-01-31	Lenkanlage
DE112005000713A5 (de)	2007-05-24	Reinigungsanlage
GB0523257D0 (en)	2005-12-21	Purification process
DK1955066T3 (da)	2014-05-05	Membran-assay-fremgangsmåde